Osteoimmune Modulation and Guided Osteogenesis Promoted by Barrier Membranes Incorporated with S-Nitrosoglutathione (GSNO) and Mesenchymal Stem Cell-Derived Exosomes

BACKGROUND: The use of polycaprolactone (PCL) for bone defects in a clinical setting is limited due to a lack of bioactivity. Exosomes derived from mesenchymal stem cells (MSCs) have an important immunoregulatory potential and together with S-nitrosoglutathione (GSNO) they possess therapeutic potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Ao, Jun, Lu, Haiping, Zhao, Qingyu, Ma, Yaping, Zhang, Jun, Ren, Hao, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237116/
https://www.ncbi.nlm.nih.gov/pubmed/32523344
http://dx.doi.org/10.2147/IJN.S248741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237116/
https://www.ncbi.nlm.nih.gov/pubmed/32523344
http://dx.doi.org/10.2147/IJN.S248741

Ejemplares similares